Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buccal articaine versus lidocaine for palatal mucosal anesthesia in maxillary dental procedures
IRCT20131205015665N8Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of articaine and lidocaine (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Change in palatal mucosal sensory threshold after buccal anesthetic injection and Change in palatal mucosal pain threshold after buccal anesthetic injection. Started Sep 2025; status: completed.
02
Drugs
articainelidocaine
Beyond the preview
Go deeper on IRCT20131205015665N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131205015665N8.